Disease · MONDO_0007009
Comparisons in its trials12
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 12 of 12
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Silodsosin vs Placebo: serious adverse events | 2 of 119 | 2 of 120 | 239 | NCT01144949 | Trial comparisons |
| Silodsosin vs Placebo: Spontaneous Stone Passage (All Stones) Without Need for Emergency Department Visits, Hospital Admissions, Surgical Intervention, or Other Interventional Procedures. | 60 of 115 | 52 of 117 | 232 | NCT01144949 | Trial comparisons |
| Silodsosin vs Placebo: Spontaneous Stone Passage (Distal Stones) Without Need for Emergency Department Visits, Hospital Admissions, Surgical Intervention, or Other Interventional Procedures. | 36 of 52 | 27 of 59 | 111 | NCT01144949 | Trial comparisons |
| Tamsulosin vs Placebo: Stone Passage | 21 of 53 | 18 of 47 | 100 | NCT00448123 | Trial comparisons |
| Tamsulosin vs Placebo: serious adverse events | 0 of 53 | 0 of 47 | 100 | NCT00448123 | Trial comparisons |
| Tamsulosin Treatment vs Placebo Treatment: Number of Participants With Stone Expulsion | 39 of 45 | 40 of 45 | 90 | NCT00831701 | Trial comparisons |
| Tamsulosin Treatment vs Placebo Treatment: Number of Participants Requiring Active Treatment | 6 of 45 | 4 of 45 | 90 | NCT00831701 | Trial comparisons |
| Tamsulosin Treatment vs Placebo Treatment: serious adverse events | 0 of 45 | 0 of 45 | 90 | NCT00831701 | Trial comparisons |
| Tamsulosin vs Placebo: serious adverse events | 0 of 28 | 0 of 25 | 53 | NCT00762424 | Trial comparisons |
| Arm 1 - Active vs Arm 2 - Placebo: Spontaneous Stone Passage Using Fisher's Exact Test | 8 of 17 | 5 of 16 | 33 | NCT02744430 | Trial comparisons |
| Arm 1 - Active vs Arm 2 - Placebo: deaths from any cause | 0 of 17 | 0 of 16 | 33 | NCT02744430 | Trial comparisons |
| Arm 1 - Active vs Arm 2 - Placebo: serious adverse events | 0 of 17 | 0 of 16 | 33 | NCT02744430 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0007009/comparisons